Phlebologie, Inhaltsverzeichnis Phlebologie 2020; 49(03): 178-179DOI: 10.1055/a-1157-4052 Gesellschaftsnachrichten Mitteilungen der Deutschen Gesellschaft für Phlebologie Empfehlungen zur Thromboseprophylaxe bei SARS-CoV-2 (COVID-19) Artikel empfehlen Abstract Volltext Referenzen Literatur 1 Guan WJ, Ni ZY, Hu Y. et al Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020 [Epub ahead of print] 2 Huang C, Wang Y, Li X. et al Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506 3 Tang N, Li D, Wang X. et al Abnormal coagulation parameters areassociated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020 [Epub ahead of print] 4 Klok FA, Kruip MJHA, van der Meer NJM. et al Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020 [Epub ahead of print] 5 Cui S, Chen S, Li X. et al Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 2020 [Epub ahead of print] 6 Tang N, Bai H, Chen X. et al Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020 [Epub ahead of print] 7 Thachil J, Tang N, Gando S. et al ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 2020 [Epub ahead of print] 8 Casini A, Alberio L, Angelillo-Scherrer A. et al Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 – a Swiss consensus statement by the Working Party Hemostasis. Swiss Med Wkly 2020; 150: w20247 9 Marietta M, Ageno W, Artoni A. et al COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfus 2020 [Epub ahead of print]
